• Deutsch
Login
Hochschule Bonn-Rhein-Sieg

Open Access

  • Home
  • Search
  • Browse
  • Publish
  • Help

Refine

Department, Institute

  • Institut für funktionale Gen-Analytik (IfGA) (3)
  • Fachbereich Angewandte Naturwissenschaften (2)

Document Type

  • Article (3)
  • Part of a Book (1)

Year of publication

  • 2019 (1)
  • 2018 (1)
  • 2013 (1)
  • 2006 (1)

Has Fulltext

  • no (3)
  • yes (1)

Is part of the Bibliography

  • no (2)
  • yes (2)

Keywords

  • Aminoacylase (1)
  • Enzyme activity assays (1)
  • Magnetic resonance imaging (MRI) (1)
  • Neurometabolic disease (1)
  • Organic aciduria (1)

4 search hits

  • 1 to 4
  • 10
  • 20
  • 50
  • 100

Sort by

  • Year
  • Year
  • Title
  • Title
  • Author
  • Author
Amino Acids and Inherited Amino Acid-Related Disorders (2018)
Knerr, Ina ; Bernstein, Laurie ; Crushell, Ellen ; O’Sullivan, Siobhan ; Sass, Jörn Oliver
Amino acids perform multiple essential physiological roles in humans, and accordingly, their importance to health has been the subject of extensive attention. In this special issue of the Journal of Nutrition and Metabolism, we focus on the various inborn errors of amino acid metabolism, their diagnostic challenges, new treatment approaches, and recent advances in patient monitoring as well as clinical outcomes.
Aspartoacylase Deficiency (Canavan Disease, N-Acetylaspartic Aciduria) (2019)
Sass, Jörn Oliver ; Knerr, Ina
CD is a rare, autosomal recessive neurometabolic disorder with often devastating clinical consequences. It typically presents in early infancy. Clinical symptoms and MRI-based findings are chronic neurological deterioration with irritability and severe global developmental delay, loss of early milestones, macrocephaly, and seizures together with white matter abnormalities in the brain (“leukodystrophy”). CD is biochemically characterized by a deficiency of aspartoacylase along with the accumulation of NAA in the brain and in body fluids, particularly in urine. In the majority of CD patients, the disease leads to early death. As there is no cure for this condition, management of affected children and their families is symptom orientated and supportive and includes a multidisciplinary medical team.
Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesity (2006)
Jung, Ronny ; Rauch, Anita ; Salomons, Gajja S. ; Verhoeven, Nanda M. ; Jakobs, Cornelis ; Michael Gibson, K. ; Lachmann, Ehrenfried ; Sass, Jörn Oliver ; Trautmann, Udo ; Zweier, Christiane ; Staatz, Gundula ; Knerr, Ina
We describe the clinical course, as well as cytogenetic and molecular findings, of a 3-year-old obese boy with psychomotor retardation who exhibited two rare conditions: succinic semialdehyde dehydrogenase deficiency (SSADH deficiency, MIM 271980), a disorder of gamma-aminobutyric acid metabolism with a heterogeneous clinical spectrum, and partial Wilms' tumor, aniridia, genital abnormalities, and mental retardation (WAGR) syndrome, an association between Wilms' tumor, aniridia, genitourinary malformations, and mental retardation due to mutations involving the short arm of chromosome 11, particularly deletions at the chromosomal region 11p13 (MIM 194072). Diagnosis of SSADH deficiency in our patient was established by demonstration of absent enzyme activity in isolated leucocytes, and was associated with a novel missense mutation (c.587G>A; p.Gly196Asp) in the SSADH coding sequence. We further confirmed an incomplete WAGR syndrome in this boy [karyotype 46, XY, del (11) (p13p14.2)] with a normal WT1 (Wilms' tumor) gene and an absence of pathology in the genitourinary tract, but with obesity (WAGR syndrome with obesity, WAGRO syndrome). The patient also exhibited distinctive cerebral anomalies such as increased signals of the globi pallidi, internal hydrocephalus and cerebellar vermian atrophy. However, treatment options for this patient are limited, including supportive treatment, physiotherapy, special educational training, and vigabatrin. In summary, we report the first patient with the exceptional rare findings of both SSADH deficiency and partial WAGR/WAGRO syndrome.
Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients (2013)
Grünert, Sarah C. ; Müllerleile, Stephanie ; Silva, Linda de ; Barth, Michael ; Walter, Melanie ; Walter, Kerstin ; Meissner, Thomas ; Lindner, Martin ; Ensenauer, Regina ; Santer, René ; Bodamer, Olaf A. ; Baumgartner, Matthias R. ; Brunner-Krainz, Michaela ; Karall, Daniela ; Haase, Claudia ; Knerr, Ina ; Marquardt, Thorsten ; Hennermann, Julia B. ; Steinfeld, Robert ; Beblo, Skadi ; Koch, Hans-Georg ; Konstantopoulou, Vassiliki ; Scholl-Bürgi, Sabine ; van Teeffelen-Heithoff, Agnes ; Suormala, Terttu ; Sperl, Wolfgang ; Kraus, Jan P. ; Superti-Furga, Andrea ; Schwab, Karl Otfried ; Sass, Jörn Oliver
BACKGROUND Propionic acidemia is an inherited disorder caused by deficiency of propionyl-CoA carboxylase. Although it is one of the most frequent organic acidurias, information on the outcome of affected individuals is still limited. STUDY DESIGN/METHODS Clinical and outcome data of 55 patients with propionic acidemia from 16 European metabolic centers were evaluated retrospectively. 35 patients were diagnosed by selective metabolic screening while 20 patients were identified by newborn screening. Endocrine parameters and bone age were evaluated. In addition, IQ testing was performed and the patients' and their families' quality of life was assessed. RESULTS The vast majority of patients (>85%) presented with metabolic decompensation in the neonatal period. Asymptomatic individuals were the exception. About three quarters of the study population was mentally retarded, median IQ was 55. Apart from neurologic symptoms, complications comprised hematologic abnormalities, cardiac diseases, feeding problems and impaired growth. Most patients considered their quality of life high. However, according to the parents' point of view psychic problems were four times more common in propionic acidemia patients than in healthy controls. CONCLUSION Our data show that the outcome of propionic acidemia is still unfavourable, in spite of improved clinical management. Many patients develop long-term complications affecting different organ systems. Impairment of neurocognitive development is of special concern. Nevertheless, self-assessment of quality of life of the patients and their parents yielded rather positive results.
  • 1 to 4

OPUS4 Logo

  • Contact
  • Imprint and Privacy policy (in German)
  • Sitelinks